This premier event brings together thousands of professionals at all levels to engage in industry-critical discussion and study the latest developments in pharmaceutical manufacturing.
NORTH BETHESDA, Md., June 22, 2023 /PRNewswire-PRWeb/ -- The International Society for Pharmaceutical Engineering (ISPE) is thrilled to announce Joydeep Ganguly, Senior Vice President of Corporate Operations at Gilead Sciences Inc, as the Executive Chair of the 2023 ISPE Annual Meeting & Expo. The event will take place from 15-18 October at the Mandalay Bay Resort in Las Vegas, Nevada, USA.
The 2023 ISPE Annual Meeting & Expo will offer a diverse range of content areas that delve into critical issues shaping the pharmaceutical industry. The robust program will offer more than 53 hours of educational content covering fundamental topics such as digital transformation, manufacturing excellence, regulatory compliance, supply chain resiliency, advanced therapy and manufacturing, and sustainability. It will also feature a Global Regulatory Town Hall and six interactive workshops on operational excellence, regulatory issues, digitalization, and more. The prestigious Facility of the Year Awards banquet, which recognizes outstanding achievements in pharmaceutical manufacturing facility design and operation, will take place during the conference.
"I am honored and privileged to serve as the Executive Chair for the 2023 ISPE Annual Meeting & Expo," said Ganguly. "This remarkable event is a pivotal gathering that brings together innovators within the industry to ignite the pharmaceutical industry. Please join me and other thought leaders as we look to share how latest advancements in our sector are shaping the future of our industry. The conference agenda has been curated to provide exclusive insights on emerging trends to position yourself at the forefront of the pharmaceutical landscape, while creating the space to forge invaluable partnerships."
In addition to collaborating, exchanging ideas, and learning with thousands of industry colleagues and leaders from around the world, conference attendees will also be able to participate in an array of networking and social activities including a hackathon and a golf tournament hosted by the ISPE Foundation.
In his current role as Senior Vice President of Corporate Operations at Gilead Sciences, Ganguly oversees Gilead's global operations across its network. Before Gilead, Joydeep spent 10 years at Biogen in roles of increasing responsibility in technical operations, manufacturing and supply chain. A transformational thought leader in the operations space, he has published extensively about operations transformation, engineering innovation and supply chain evolution. Joydeep earned a Master of Science in Electrical Engineering from the University of Notre Dame, a Master of Business Administration from North Carolina State University, and a master's degree in healthcare administration from Cornell University. Recently recognized as a Top 50 Diverse Leader in California, Joydeep sits on the Boards of the Bay Area Council, Biocom, the Gilead Foundation, and was recently appointed to the Board of Advisors at Culture Biosciences.
Registration for the 2023 ISPE Annual Meeting & Expo is now open: https://ispe.org/AM23
About ISPE
"The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 20,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.
Media Contact
Jessica Bleess, Associate Vice President of Conferences and Digital Engagements, ISPE, 813-739-2289 x280, [email protected]
SOURCE ISPE
Share this article